KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $21.4 million.

  • Neogenomics' Prepaid Assets rose 633.77% to $21.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $21.4 million, marking a year-over-year increase of 633.77%. This contributed to the annual value of $21.4 million for FY2025, which is 633.77% up from last year.
  • Neogenomics' Prepaid Assets amounted to $21.4 million in Q4 2025, which was up 633.77% from $22.0 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Prepaid Assets peaked at $23.0 million during Q1 2025, and registered a low of $11.1 million during Q1 2021.
  • In the last 5 years, Neogenomics' Prepaid Assets had a median value of $17.7 million in 2023 and averaged $17.8 million.
  • In the last 5 years, Neogenomics' Prepaid Assets soared by 8687.8% in 2022 and then plummeted by 2178.51% in 2023.
  • Quarter analysis of 5 years shows Neogenomics' Prepaid Assets stood at $12.4 million in 2021, then rose by 23.34% to $15.2 million in 2022, then grew by 18.05% to $18.0 million in 2023, then rose by 12.11% to $20.2 million in 2024, then grew by 6.34% to $21.4 million in 2025.
  • Its last three reported values are $21.4 million in Q4 2025, $22.0 million for Q3 2025, and $22.8 million during Q2 2025.